FDA Inspection 1041826 — CTX Lifesciences Private Ltd.
The FDA completed an inspection of CTX Lifesciences Private Ltd. on January 30, 2018 in Surat. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 30, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Surat (India)